Paul Mathais
Analyst
Stifel
Equibles does not estimate personal net worth.
About Paul Mathais
Paul Mathais is recorded as Analyst at Stifel. Paul Mathais has spoken on 1 earnings call across 1 company, most recently for Rhythm Pharmaceuticals, Inc. on May 5, 2026. The companies whose calls Paul Mathais spoke on are classified in the Healthcare sector.
Paul Mathais on recent calls
“Taking a step back, it feels like with a number of rare disease launches lately, the street just debates whether early success is a bolus or linear and sustainable.”
Affiliation history
-
Stifel
Analyst
Transcript header (unverified)
Current